Suchergebnisse - "Neuroblastoma"

PubPharm (11.588)

61

2,3,7,8-Tetrachlorodibenzo-p-dioxin and kynurenine induce Parkin expression in neuroblastoma cells through different signaling pathways mediated by the aryl hydrocarbon receptor

enthalten in: Toxicology letters | 2024

von Murillo-González, F. | García-Aguilar, R. | Limón-Pacheco, J. | +2

62

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer : Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms

enthalten in: ClinicalTrials.gov | 2024

63

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) : NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Erdafitinib in Patients With Tumors Harboring FGFR1/2/3/4 Alterations

enthalten in: ClinicalTrials.gov | 2024

64

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) : NCI-COG Pediatric MATCH (Molecular Analysis For Therapy Choice)- Phase 2 Subprotocol of LY3023414 in Patients With Solid Tumors

enthalten in: ClinicalTrials.gov | 2024

65

Impaired Aortic Growth in Neuroblastoma Patients After Intensive Treatment

enthalten in: Journal of pediatric surgery | 2024

von Takenouchi, A. | Kudo, W. | Terui, K. | +7

66

Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma : A Phase II Trial of Nifurtimox for Refractory or Relapsed Neuroblastoma or Medulloblastoma.

enthalten in: ClinicalTrials.gov | 2024

67

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma : A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

enthalten in: ClinicalTrials.gov | 2024

68

Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide : A Phase I Trial for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide

enthalten in: ClinicalTrials.gov | 2024

69

Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma : A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Refractory or Recurrent Neuroblastoma

enthalten in: ClinicalTrials.gov | 2024

70

Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma : A Phase I/II Trial of TPI-287 in Patients With Refractory or Recurrent Neuroblastoma and Medulloblastoma

enthalten in: ClinicalTrials.gov | 2024